Background illustration for clinical trials search

Eczema Clinical Trials

Browse 98 eczema clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
FeaturedActive & ResponsiveNew

Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With Delgocitinib Cream

for
Chronic Hand Eczema (CHE)
Location: Montgomery AL
Sponsor: LEO Pharma

Sex: All

Age: 18+

Code: NCT07603193

Recruiting
Featured

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

for
Atopic Dermatitis
Location: Camp Hill PA, Markham, Newmarket, Mississauga, Tampa FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07223697

Phase2, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Montreal, Lanham MD, Coral Gables FL, Charleston SC,
Sponsor: AbbVie

Sex: All

Age: 2 - 11

Code: NCT06461897

Phase3, Recruiting
Active & Responsive

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

for
Atopic Dermatitis
Location: The Bronx NY, New York NY, Irvine CA
Sponsor: Bambusa Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06808477

Phase1, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema
Location: Woodbury NY, Kew Gardens NY, New York NY, Montreal,
Sponsor: Inmagene LLC

Sex: All

Age: 18 - 70+

Code: NCT07037901

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

for
Healthy Participants, Atopic Dermatitis
Location: Philadelphia PA, Miami FL, Troy MI, San Diego CA,
Sponsor: Pfizer

Sex: All

Age: 18 - 70

Code: NCT06564389

Phase1, Recruiting
Active & Responsive

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Johnston RI, Quebec, Chicoutimi, New York NY,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05995964

Phase2, Recruiting
Active & ResponsiveNew

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

for
Atopic Dermatitis (Eczema), Psoriasis
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT07487831

Recruiting
Active & Responsive

Dupilumab De-escalation in Pediatric Atopic Dermatitis

for
Atopic Dermatitis
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 1 - 17

Code: NCT06116526

Recruiting
Active & Responsive

Metabolic Profiling of Immune Responses in Immune-mediated Diseases

for
Primary Immunodeficiency, Psoriasis, Atopic Dermatitis,
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT04864886

Recruiting
Active & Responsive

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

for
Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides,
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT00177268

Recruiting
Active & Responsive

Registry for Systemic Eczema Treatments

for
Atopic Dermatitis
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 1 - 26

Code: NCT06136767

Recruiting
Active & Responsive

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

for
Atopic Dermatitis (AD), Psoriasis (PsO)
Location: Fargo ND, Dallas TX
Sponsor: LAPIX Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06982352

Phase1, Recruiting
Active & Responsive

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

for
Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema,
Location: South San Francisco CA
Sponsor: Corvus Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07441395

Phase2, Recruiting
Active & Responsive

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

for
Eczema Atopic Dermatitis, Eczema, Atopic Dermatitis
Location: Irving TX
Sponsor: Turn Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07355075

Phase2, Phase3, Recruiting
Active & Responsive

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis (AD)
Location: New York NY, Norfolk VA, Wilmington NC, Camp Hill PA,
Sponsor: Enveda Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07298395

Phase2, Recruiting
Active & Responsive

Sodium in the Skin and Atopic Dermatitis

for
Eczema, Atopic Dermatitis
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 50+

Code: NCT06998446

Recruiting
Active & Responsive

The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

for
Atopic Dermatitis (AD)
Location: Pittsburgh PA
Sponsor: Daniel Kaplan

Sex: All

Age: 18+

Code: NCT06928246

Phase1, Recruiting
Active & Responsive

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

for
Atopic Dermatitis
Location: Fredericton, Quebec, New York NY, Montreal,
Sponsor: Apogee Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07003425

Phase2, Recruiting
Active & Responsive

THC Titration of High-Potency Cannabis Concentrates

for
THC
Location: Toronto
Sponsor: Centre for Addiction and Mental Health

Sex: All

Age: 19 - 55

Code: NCT07105449

Recruiting